EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Ten Years of B3 Lesions in a Certified Breast Center: Toward a Risk-Adapted Management Strategy – a retrospective cohort study

Michael Bolliger, Rintaro Fujita, Daphne Resch, Michael Schleifer, Agnes Voß, Markus Reiter, Stephanie Kampf, Alexandra Resch

Breast Care · 14.11.2026

DOI: 10.1159/brc/abrag018 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Breast Care, online erschienen am 14.11.2026. Verfasst von Michael Bolliger und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Austria implemented a successful breast cancer screening program over ten years ago. With high-resolution imaging techniques and the expansion of screening programs, lesions of uncertain malignant potential (B3 lesions) are detected more frequently. However, current guidelines provide limited recommendations regarding their optimal management. This study evaluates the clinical and surgical implications of B3 lesions over the first decade of the Austrian screening program in a specialized breast health center.

Methods

Patient data from 2015 to 2025 was retrospectively analyzed. Inclusion required a preoperative B3 diagnoses via image-guided biopsy and surgical excision at our breast health center. Baseline demographics, histologic subtypes, upgrade rates to malignancy and clinical follow-up were evaluated.

Results

Out of 108 identified B3 lesions, 90 surgical cases could be analyzed. Mean age was 48.22 ± 12.56 years. Premenopausal women, defined as younger than 50 years, accounted for 64.4% of the cohort. Mean interval from biopsy to surgery was 51 ± 56.48 days. Atypical ductal hyperplasia (ADH) was the most frequent lesion (n=49) with an 18.4% upgrade rate to malignancy. Papillary lesions (n=16) showed an upgrade rate of 12.5%. Overall 15 lesions were upgraded to malignancy, corresponding to a cumulative upgrade rate of 16.7%.

Conclusions

Although B3 lesions represented less than 0.1% of all screened women in our cohort, they generated an additional workload of approximately 10% annually in our center. Given the comparatively low subtype-specific upgrade rates,our findings support aligning local breast center workflows with international consensus guidelines toward a more selective, risk-adapted management strategy.

Zitieren

APA

Bolliger, M., Fujita, R., Resch, D., Schleifer, M., Voß, A., Reiter, M., Kampf, S., & Resch, A. (2026). Ten Years of B3 Lesions in a Certified Breast Center: Toward a Risk-Adapted Management Strategy – a retrospective cohort study. Breast Care. https://doi.org/10.1159/brc/abrag018

Vancouver

Bolliger M, Fujita R, Resch D, Schleifer M, Voß A, Reiter M, et al. Ten Years of B3 Lesions in a Certified Breast Center: Toward a Risk-Adapted Management Strategy – a retrospective cohort study. Breast Care. 2026. doi:10.1159/brc/abrag018

BibTeX
@article{Bolliger2026,
  author = {Bolliger, Michael and Fujita, Rintaro and Resch, Daphne and Schleifer, Michael and Voß, Agnes and Reiter, Markus and Kampf, Stephanie and Resch, Alexandra},
  title = {Ten Years of B3 Lesions in a Certified Breast Center: Toward a Risk-Adapted Management Strategy – a retrospective cohort study},
  journal = {Breast Care},
  year = {2026},
  doi = {10.1159/brc/abrag018}
}
Kostenlos starten →